14.

SEGMENT INFORMATION

 

The Company follows ASC 280, “Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Consolidated Financial Statements).

 

The Company reports segment information based on the management approach, which designates the internal reporting used by the Chief Operating Decision Makers (“CODMs”), who were Bradley Vizi, Chief Executive Officer, and Kevin Miller. Chief Financial Officer. The Company’s CODMs are responsible for making decisions regarding the Company’s business, including resource allocations and performance assessments based on historical and future segment revenue, operating expenses, and operating income (loss) before interest and taxes.

 

In the second quarter of fiscal 2025, the Company made certain revisions to the internal measurement of segment operating results for the purpose of evaluating segment performance and resource allocation. The revised segment reporting now presents corporate operating costs separately instead of allocating them to the operating segments. The revision was the result of a shift in the CODM’s more granular and independent focus on the now four segments. We have presented the revised segment results for both fiscal 2025 and the prior period on a comparable basis.

 

The following tables summarize the results of operations and total assets by segment provided to the CODMs. Segment operating income (loss) includes selling, general, and administrative expenses directly attributable to that segment. The following tables reflect the results of the reportable segments consistent with the Company’s management system. Please refer to the segment discussion of the Management’s Discussion and Analysis of Financial Condition and Results of Operations section of this Annual Report on Form 10-K.

 

Fiscal Year Ended

January 3, 2026

 

Specialty

Health Care

  

Engineering

  

Life Sciences,

Data &

Solutions

  

Corporate

  

Total

 
                     

Revenue

 $164,104  $120,486  $34,814  $-  $319,404 
                     

Cost of services

  116,702   93,104   21,655   -   231,461 
                     

Gross profit

  47,402   27,382   13,159   -   87,943 
                     

Selling, general and administrative

  24,220   11,976   6,694   18,042   60,932 
                     

Depreciation and amortization of property and equipment

  393   771   148   606   1,918 
                     

Operating income (loss)

 $22,789  $14,635  $6,317  $(18,648) $25,093 
                     

Total assets as of January 3, 2026

 $46,541  $60,562  $13,936  $13,358  $134,397 

Property and equipment acquired

 $238  $480  $36  $841  $1,595 

 

Fiscal Year Ended

December 28, 2024

 

Specialty

Health Care

  

Engineering

  

Life Sciences,

Data &

Solutions

  

Corporate

  

Total

 
                     

Revenue

 $142,679  $96,459  $39,242  $-  $278,380 
                     

Cost of services

  100,146   73,916   24,540   -   198,602 
                     

Gross profit

  42,533   22,543   14,702   -   79,778 
                     

Selling, general and administrative

  22,213   11,869   6,875   15,830   56,787 
                     

Depreciation and amortization of property and equipment

  386   613   150   270   1,419 
                     

Amortization of acquired intangible assets

  -   -   683   -   683 
                     

Potential stock issuance and financing transactions

  -   -   -   323   323 
                     

Remeasurement of contingent consideration

  -   -   (1,759)  -   (1,759)
                     

Operating income (loss)

 $19,934  $10,061  $8,753  $(16,423) $22,325 
                     

Total assets as of December 28, 2024

 $43,180  $52,160  $22,210  $14,527  $132,077 

Property and equipment acquired

 $296  $691  $28  $1,557  $2,572 

 

The Company derives a majority of its revenue from offices in the United States. Revenue reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Germany, Philippines, Puerto Rico and Europe. The Company does not derive any revenue in the Philippines. Revenue by geographic area for the fiscal years ended January 3, 2026 and December 28, 2024 are as follows:

 

  

Fiscal Year Ended

 
  

January 3,

  

December 28,

 
  

2026

  

2024

 

Revenue

        

United States

 $290,187  $256,759 

Canada

  7,535   7,196 

Puerto Rico

  6,363   7,017 

Europe

  15,319   7,408 
  $319,404  $278,380 

 

Total assets by geographic area as of the reported periods are as follows:

 

  

Fiscal Year Ended

 
  

January 3,

  

December 28,

 
  

2026

  

2024

 

Total Assets

        

United States

 $123,021  $123,905 

Canada

  1,828   1,423 

Puerto Rico

  2,637   3,286 

Europe

  6,594   3,408 

Philippines

  317   55 
  $134,397  $132,077 

 

Historical Timeline

Fiscal YearFiled
2026Apr 3, 2026Showing above
2024Mar 13, 2025

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.